S. Myhre, Rob W.H. Ruigrok, Leif Lindholm, Pierre Boulanger, Saw See Hong, Laure Franqueville, Ewa Szolajska, Guy Schoehn, Jadwiga Chroboczek, Virologie et pathogenèse virale (VPV), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Institute of Biochemistry and Biophysics, Polska Akademia Nauk = Polish Academy of Sciences (PAN), Institut de biologie structurale (IBS - UMR 5075 ), Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Laboratoire de virologie moléculaire et structurale (LVMS), Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF), Department of Medical Microbiology and Immunology [Göteborg], University of Gothenburg (GU), Got-A-Gene AB, Stena Center 1B, E.S. was supported by fellowships from the EMBO, FEBS and FRM (Fondation pour la Recherche Médicale), successively. We are indebted to J.-P. Andrieu for the N-terminal amino acid analysis and to B. Dublet for mass spectrometry. We are indebted to Dr Felipe Andrade (Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion 'Salvador Zubiran', Mexico City, Mexico) for the gift of anti-100K polyclonal antibody and to Professor Willie Russell (University of St. Andrews, Scotland) for the anti-hexon monoclonal antibody 4C3. This work was supported, in part, by grants from VLM (French Foundation for Cystic Fibrosis, Contract no. TG-0402), and AFM (Association Française contre les Myopathies, Contracts no. D09481A/S00634 and D10902A/S00634)., Virologie et Pathologie Humaine (VirPath), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS), Got-a-Gene AB, Department of Microbiology and Immunology, Laboratoire de Virologie Moléculaire et Structurale, FRE 2854 CNRS/UJF, c/o EMBL BP 181, 38042 Grenoble Cedex 9, France, Polska Akademia Nauk = Polish Academy of Sciences (PAN)-Sciences, FRE 2854 CNRS/UJF, Laboratoire de Virologie-Moleculaire et Structurale, Stena Center, EMBO, FEBS and FRM (Fondation pour la Recherche Me´dicale), successively. We are indebted to J.-P. Andrieu for the N-terminal amino acid analysis and to B. Dublet for mass spectrometry.We are indebted to Dr Felipe Andrade (Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion 'Salvador Zubiran', Mexico City, Mexico) for the gift of anti- 100K polyclonal antibody and to Professor Willie Russell (University of St. Andrews, Scotland) for the anti-hexon monoclonal antibody 4C3. This work was supported, in part, by grants from VLM (French Foundation for Cystic Fibrosis, Contract no. TG-0402), and AFM (Association Franc¸aise contre les Myopathies, Contracts no. D09481A/ S00634 and D10902A/S00634)., Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), and Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS)